Enanta Enters Into Strategic Collaboration With Novartis For EDP-239

Novartis: Gilenya Effective Against 4 Measures Of Disease Activity In MS

Novartis Says Gilenya Improves All 4 Key Measures Of Multiple Sclerosis

Novartis Says Therapy LDK378 Shows Marked Clinical Response

Novartis Says BOLERO-3 Trial Meets Primary Endpoint

Trade NVS now with

2/21/2012 2:05 PM ET

Private Equity Holding AG or PEH announced that a portfolio company Enanta Pharmaceuticals has entered into a strategic collaboration with Novartis AG (NVS: Quote) for the worldwide development, manufacture and commercialization of its lead development candidate, EDP-239, from its NS5A hepatitis C virus or HCV inhibitor program.

PEH is a minority shareholder and invested in Enanta in 1999 as part of the original shareholder syndicate.

Click here to receive FREE breaking news email alerts for Novartis AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 77 Articles

Editors Pick

China May Leading Index Signals Weaker Economic Growth Ahead

A leading indicator of Chinese economic activity rose marginally in May and at a slower pace than a month earlier, suggesting more sluggish growth for the overall economy in the months ahead. The Conference Board said that its leading economic indicator rose 0.3 percent month-on-month in May, slower than a 1.5 percent increase in April. Only three of the six components contributed positively.

Stocks Close Mostly Higher Despite Afternoon Pullback - U.S. Commentary

While lingering worries about the outlook for the Federal Reserve's stimulus program generated some selling pressure in afternoon trading on Monday, stocks managed to end the day mostly higher after seeing an early rally on the heels of some upbeat economic data. The major averages finished the session well off their best levels of the day but still posted strong gains.

Poll Shows Sharp Drop In Obama's Approval Rating

In an apparent backlash from the numerous scandals facing the administration, the results of a new CNN/ORC International survey released Monday showed a sharp drop in President Barack Obama's approval rating. The poll found that 45 percent of Americans approve of the way Obama is handling his job as president, down from 53 percent in a poll conducted last month.